Abstract |
Glucagon has been reported to improve exercise tolerance in some patients with myophosphorylase deficiency ( McArdle's disease) but a placebo effect was not excluded in previous trials. A single-blind controlled trial of glucagon in a patient with myophosphorylase deficiency is described. Although an improved exercise endurance of the forearm muscles was demonstrated with both short-acting and depot- glucagon, this was not statistically significant when compared with placebo or no treatment.
|
Authors | T J Day, F L Mastaglia |
Journal | Australian and New Zealand journal of medicine
(Aust N Z J Med)
Vol. 15
Issue 6
Pg. 748-50
(Dec 1985)
ISSN: 0004-8291 [Print] Australia |
PMID | 3869441
(Publication Type: Case Reports, Clinical Trial, Controlled Clinical Trial, Journal Article)
|
Chemical References |
- Delayed-Action Preparations
- Glucagon
|
Topics |
- Adult
- Delayed-Action Preparations
- Female
- Glucagon
(administration & dosage, therapeutic use)
- Glycogen Storage Disease
(drug therapy)
- Glycogen Storage Disease Type V
(drug therapy)
- Humans
- Muscles
(physiology)
- Physical Endurance
(drug effects)
|